0.0001
0.0000
(0.00%)
At close: January 10 at 3:00:00 PM EST
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Expense
38,492.0000
38,492.0000
35,870.0000
26,257.0000
Operating Income
-38,492.0000
-38,492.0000
-35,870.0000
-26,257.0000
Net Non Operating Interest Income Expense
501.0000
501.0000
-719.0000
198.0000
Pretax Income
-37,991.0000
-37,991.0000
-36,589.0000
-26,059.0000
Net Income Common Stockholders
-37,991.0000
-37,991.0000
-36,589.0000
-26,059.0000
Diluted NI Available to Com Stockholders
-37,991.0000
-37,991.0000
-36,589.0000
-26,059.0000
Basic EPS
-4.55
-4.55
-4.93
-3.88
Diluted EPS
-4.55
-4.55
-4.93
-3.88
Basic Average Shares
8,343.4550
8,343.4550
7,419.8440
6,030.5260
Diluted Average Shares
8,343.4550
8,343.4550
7,419.8440
6,030.5260
Total Expenses
38,492.0000
38,492.0000
35,870.0000
26,257.0000
Net Income from Continuing & Discontinued Operation
-37,991.0000
-37,991.0000
-36,589.0000
-26,059.0000
Normalized Income
-37,991.0000
-37,991.0000
-36,589.0000
-26,059.0000
Interest Income
501.0000
501.0000
188.0000
225.0000
Interest Expense
--
--
907.0000
27.0000
Net Interest Income
501.0000
501.0000
-719.0000
198.0000
EBIT
-38,492.0000
-38,492.0000
-35,682.0000
-26,032.0000
EBITDA
-37,490.0000
-37,490.0000
-35,141.0000
-25,648.0000
Reconciled Depreciation
1,002.0000
1,002.0000
541.0000
384.0000
Net Income from Continuing Operation Net Minority Interest
-37,991.0000
-37,991.0000
-36,589.0000
-26,059.0000
Normalized EBITDA
-37,490.0000
-37,490.0000
-35,141.0000
-25,648.0000
12/31/2020 - 4/8/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
63E.SG Onward Medical N.V.
6.32
+17.04%
RIGL Rigel Pharmaceuticals, Inc.
16.25
0.00%
GLPG.AS Galapagos NV
25.06
-6.00%
SXTP 60 Degrees Pharmaceuticals, Inc.
1.0500
-3.67%
VRAX Virax Biolabs Group Limited
2.4200
+3.42%
CGTX Cognition Therapeutics, Inc.
0.7609
-3.27%
OTLK Outlook Therapeutics, Inc.
2.3700
+8.72%
IBIO iBio, Inc.
2.5500
-6.25%
ABCL AbCellera Biologics Inc.
2.9200
-3.63%
IBRX ImmunityBio, Inc.
2.4200
-5.47%